Loading...
Please wait, while we are loading the content...
Similar Documents
Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia
| Content Provider | Scilit |
|---|---|
| Author | Webster, Jonathan A. Tibes, Raoul Morris, Larry Blackford, Amanda L. Litzow, Mark Patnaik, Mrinal Rosner, Gary L. Gojo, Ivana Kinders, Robert Wang, Lihua Doyle, L. Austin Huntoon, Catherine J. Karnitz, Larry M. Kaufmann, Scott H. Karp, Judith E. Smith, B. Douglas |
| Copyright Year | 2017 |
| Description | Journal: Leukemia Research |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639924/pdf |
| Ending Page | 116 |
| Page Count | 9 |
| Starting Page | 108 |
| ISSN | 01452126 |
| e-ISSN | 18735835 |
| DOI | 10.1016/j.leukres.2017.09.005 |
| Journal | Leukemia Research |
| Volume Number | 61 |
| Language | English |
| Publisher | Elsevier BV |
| Publisher Date | 2017-10-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: Leukemia Research |
| Content Type | Text |
| Resource Type | Article |
| Subject | Hematology Cancer Research Oncology |